Financial News
Articles published by QIAGEN N.V.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
March 09, 2023
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
March 01, 2023
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
February 14, 2023
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
January 17, 2023
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
December 13, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
November 21, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast
October 21, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System
September 15, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
September 14, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Issues 2021 Sustainability Report
August 18, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
August 15, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
July 19, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From QIAGEN N.V.
Via Business Wire
Tickers
QGEN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.